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doi:10.1016/j.ijid.2004.04.014Objective: This study aims to investigate the Helicobacter pylori antigen in the stool
samples of patients suspected to have H. pylori infection. It also aims to determine
the fecoprevalence in different age groups and to look for the relationship between
the clinical symptoms seen in patients and the existence of H. pylori. Current
information in Turkey is insufficient.
Methods: The Helicobacter pylori antigen was investigated in the stool samples of
445 patients of whom 148 were in the 2—15 year age group, 96 in the 16—30 year age
group, 85 in the 31—40 year age group and 116 in the 41—48 year age group. The main
clinical complaints of the patients (stomach pain, heart burn, indigestion, gas,
nausea, vomiting, diarrhea, abdominal pain) were recorded.
Results: The Helicobacter pylori antigen was found in 36.6% (163/445) of the patients
and in the statistical evaluation made for different age groups, a significant linear
relationship was found between age and infection (x2 = 14.77, p = 0.002).
Conclusion: It was found that stomach pain was seen at a higher rate in patients with
H. pylori antigen compared to those without it. The difference was highly statistically
significant (x2 = 117.70, p < 0.001, OR = 20.36, 95% CI = 10.56—39.27).
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Helicobacter pylori causes several gastric diseases
ranging from gastritis to peptic ulcer. Furthermore,
H. pylori is considered to play a role in the devel-
opment of gastric cancer and gastric mucosa-asso-
ciated lymphoid tissue (MALT) lymphoma. Infection
with H. pylori is very common throughout the world.
Although there are significant differences in the
prevalence of H. pylori infection, both within and
between countries, it occurs in approximately
40—50% of the population in developed countries
and 80—90% of the population in developing coun-
tries.1—3
Various diagnostic tests are available for the
detection of H. pylori infection and these can be
grouped into invasive and non-invasive. Tests that
require endoscopy include the biopsy urease test,
histology, culture, PCR-based methods, and phase-
contrast microscopy of gastric tissue. Diagnostic
tests that do not require endoscopy include the
13C-or 14C-labeled urea breath test, serology, the
string test and the stool antigen enzyme immunoas-
say (EIA).4
Over the last few years, although H. pylori has
been cultured from stool samples, it has been shown
that viable organisms are present only in a small
percentage of cases.4—7
Despite the difficulties encountered in the cul-
ture from stool samples, the fact that dead and/or
alive organisms were present in all the stools raised
the possibility of developing a new non-invasive
diagnostic test for the detection of the H. pylori
antigen in stools. Premier Platinum HpSA (Meridian
Diagnostic Inc., Cincinnati, Ohio, USA) has devel-
oped an in-vitro qualitative enzyme immunoassay
commercial kit which states that it can detect
H. pylori protein antigens when present at a con-
centration of 184 ng/ml of feces.4
Because information on the prevalence of H.
pylori infection is insufficient in Turkey, this study
aims to investigate the H. pylori antigen in the stool
samples of patients suspected to have H. pylori
infection and to conduct a statistical evaluation
with respect to age groups. This will then determine
the fecoprevalence in different age groups and look
for the relationship between the existence of the
H. pylori antigen and the clinical symptoms.Materials and methods
Patients
This study investigated outpatients who presented
at the Department of Gastroenterology of the Inter-nal Medicine Clinic and the Pediatric Gastroenter-
ology Clinic of the Istanbul Faculty of Medicine who
were suspected to have H. pylori infection and
whose stool samples were sent to the Department
of Microbiology and Clinical Microbiology for H.
pylori antigen examination. The H. pylori antigen
was investigated in the stool samples of 445 patients
suspected to have H. pylori infection, of which 148
were in the 2—15 year age group, 96 in the 16—30
year age group, 85 in the 31—40 year age group and
116 in the 41—85 year age group. Data relating to
these patients were recorded using a questionnaire.
The patients were asked their age and main clinical
complaints, such as stomach pain, heart burn, indi-
gestion, gas, nausea, vomiting, diarrhea, and
abdominal pain. Patients who complained of dis-
crete stomach pain or gastric pain were placed in
the stomach pain group, while those who com-
plained of pain more diffuse over the abdomen were
placed in the abdominal pain group.
Antigen detection in stool
A commercial kit was used: Premier Platinum HpSA
(Meridian Diagnostic, Ohio, USA). This sandwich
enzyme immunoassay procedure employs polyclonal
anti-H. pylori antibodies. The stool samples were
stored at 2—8 8C for up to three days (for >3 days at
20 8C) before the test. A small portion of the
specimen in diluent, positive and negative controls
were added to each antibody-coated microwell.
After adding one drop of enzyme conjugate to each
well, the plate was incubated for one hour at room
temperature, then the wells were washed five times
to remove the unbound material. Two drops of
substrate were added and incubated for 10 minutes
at room temperature. In the presence of bound
H. pylori antigens, a color develops. One-drop stop
solution was added and the results were evaluated
by spectrophotometric determination of absor-
bance at dual wavelength (450/630 nm). A D 450/
630 of 150 was considered positive.
Statistical analysis
Statistical analysis was performed with the x2 test,
Fisher’s Exact test, and step-wise logistic regression
analysis.Results
The H. pylori antigen was detected in 163 (36.6%)
patients. The distribution of the patients with H.
pylori infection with respect to age group is given in
Table 1. In the statistical analysis carried out with
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Table 1 The age group distribution of the patients
whose stool samples were positive for the Helicobacter
pylori antigen.
Age group HpSA (+)
n (%)
2—15 (n = 148) 37 25.0
16—30 (n = 96) 36 37.5
31—40 (n = 85) 36 42.3
41—78 (n = 116) 54 46.5
x2 = 14.77, p = 0.002.respect to age groups, a significant linear relation-
ship between age and infection (x2 = 14.77,
p = 0.002) was observed. The clinical symptoms of
the patients and the positive and negative results
obtained from the stool samples are compared in
Table 2.
Among the 163 patients in whom the H. pylori
antigen was found, 152 (93.2%) had stomach pain as
the most common complaint, while among the 282
patients in whom H. pylori antigen was not found,
114 (40.4%) had stomach pain as the common
complaint. The difference was statistically signifi-
cant (x2 = 117.70, p < 0.001, OR = 20.36, 95%
CI = 10.56—39.27). When complaints of the patients
with the H. pylori antigen (stomach pain, stomach
pain + nausea and vomiting, stomach pain + indiges-
tion + gas) were compared with the complaints of
the patients without the H. pylori antigen, it was
found that the difference was highly significant
(Table 2).
A logistic model was constructed in which the
HpSA (+)/() variable was taken as the dependent
variable, and stomach pain, stomach pain + indiges-
tion + gas, stomach pain + nausea and vomiting,
which were found to be statistically significant in
the bivariate analysis, were taken as independent
variables and the model was solved by a stepwise
logistic regression analysis. The results of the ana-
lysis are shown in Table 3. Variables showing HpSA
positivity were stomach pain, stomach pain + indi-
gestion + gas. In HpSA (+) cases, the presence ofTable 2 Comparison of clinical symptoms between HpSA p
Clinical symptoms HpSA (+) HpSA (
n = 163 (%) n = 282
Stomach pain 55 33.7 50
Stomach pain + heart burn 25 15.3 29
Stomach pain + nausea + vomiting 35 21.5 0
Stomach pain + indigestion + gas 37 22.7 35
Nausea + vomiting 3 1.8 68
Abdominal pain 7 4.3 57
Diarrhea 0 — 43
OR = odds ratio; CI: confidence interval; *a gallstone in one patienstomach pain was 22.51 times higher than in HpSA
() cases (OR = 22.51, 95% CI 11.47—44.19), and the
presence of stomach pain + indigestion + gas was
5.16 times (OR = 5.16, 95% CI 1.0425.48) higher
than in HpSA () cases. There was a significant
relationship between the absence of the H. pylori
antigen and the symptoms of stomach pain + heart
burn, nausea and vomiting, abdominal pain and
diarrhea.Discussion
Helicobacter pylori is the cause of gastritis, gastric
and duodenal ulcer. In addition, the association
between H. pylori and gastric carcinoma and lym-
phoma is becoming clear.8 Moreover, H. pylori is also
being investigated for contributing to extragastroin-
testinal disorders, such as impaired growth, coron-
ary heart disease, diabetes and gallstone disease.9
Currently available tests for the diagnosis of H.
pylori infection have relatively high sensitivities and
specificities but each has its limitations in clinical
application. Urease-based biopsy tests require
endoscopy and are not reliable in patients taking
proton-pump inhibitors. Histologic examination also
requires endoscopy and is subject to sampling error.
Its accuracy is dependent on the stain selected and
on the pathologist’s skill. Serology is inexpensive but
is not reliable for determining the presence of
active infection. On the other hand, it has been
found that serology in the post-treatment follow-up
period has 97% sensitivity and 95% specificity. It has
also been reported that a 50% decrease in the anti-
body titer six months after the treatment indicates
the success of the treatment.4,10—13
Overall, studies using pretreatment stool H.
pylori antigen tests have shown that the sensitivity
and specificity of stool antigen testing are compar-
able to histology, culture or urea breath test
(UBT).14—26
Sykora et al.22 investigated the biopsy samples
of 91 children (average age 12.6  3.5) with aositive and negative patients.
) p two-tailed significance OR 95% CI
(%)
17.7 p = 0.0002 2.36 1.51—3.69
10.3 p = 0.15 1.58 0.89—2.80
p < 0.001 156,09 9.49—2566
12.4 p = 0.006 2.07 1.24—3.45
24.1 p < 0.001 16.94 5.3—54.85
20.2 p < 0.001 5.64 2.50—12.70
15.2 p < 0.001 59.39 13.62—972.27
t.
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Table 3 Results of logistic regression analysis.
Independent variables B SE df Significance OR 95% CI
Stomach pain 3.11 0.34 1 p < 0.001 22.51 11.47—44.19
Stomach pain + indigestion + gas 1.64 0.81 1 p = 0.044 5.16 1.04—25.48
Constant 12.03 15.03 1 p = 0.423
OR = odds ratio; SE: standard error; df: degrees of freedom.rapid urease test and histology and found H. pylori
infection in 31 (34.1%) of cases. They observed H.
pylori antigen in the stool samples of 28 of these
children and reported the sensitivity of the test as
90.3%. They did not find H. pylori antigen in the
stool samples of the 60 children who were found to
be negative in the histologic examination and rapid
urease test, thus specificity was 100%. Van Doorn et
al.24 searched for H. pylori infection in 106 chil-
dren with an average age of 8.5 years by using
culture and histologic methods and compared their
findings with EIA for H. pylori antigen in the stool.
They found H. pylori infection in 30 (28%) children
by culture and histologic investigation, and
observed the H. pylori antigen in stool samples
of all of these children. They reported the sensi-
tivity of HpSA (EIA) as 100% and specificity as 92%.
Vaira et al.20 observed that in one prospective
multicenter trial with 501 patients with H. pylori
infection, the stool antigen for H. pylori was posi-
tive in 256 of 272 patients (sensitivity, 94.1%; 95%
CI, 91—97%). This was determined by histology and
a rapid urease test or culture. Of the 219 patients
without infection, 201 tested negative to HpSA
(EIA) (specificity, 91.8%; 95% CI, 87—95%). Gisbert
and Pajares27 evaluated the results from 43 studies
(4769 patients). They investigated the validity of
the HpSA (EIA) test in the diagnosis of H. pylori
infection in patients who were not under treat-
ment. Their results show that sensitivity is 92.4%
(95% CI = 91—93%), specificity is 91.9% (95%
CI = 91—92%), PPV is 92.1% (95% CI = 91—93%),
NPV is 90.5% (95% CI=90—91%) and that HpSA
(EIA) test in stool is a good non-invasive method
for H. pylori diagnosis.
In Turkey there have been previous studies
where H. pylori fecoprevalence has been investi-
gated. In one previous study carried out in Turkey,
H. pylori infection was diagnosed in 55% of 22
children with repeating abdominal pains whose
average age was 12.2  2.0 (median 12.5, range
9—15) by using a rapid urease test and histologic
investigation.28 In the present study, H. pylori
infection was detected in 25% of children in the
2—15 year age group by using HpSA (EIA) and no
relationship was found between abdominal pain
and H. pylori infection.In a study in Turkish children in the 1—4 year age
group who lived in Germany and who were thought
to be in the high risk group, H. pylori prevalence was
found to be 27%. A 35% decrease in infection was
observed after one year in the same group of chil-
dren and H. pylori colonization was not found to be
persistent at young ages. Furthermore the investi-
gators mentioned that the use of penicillin and
macrolides had an important role in the decrease
of infection.25
Sykora et al.22 determined H. pylori infection in
34.1% of 91 children with symptoms of indigestion at
the average age of 12.6  3.5 years by using the
rapid urease test and histologic investigation, in
Slovakia. Cheng et al.29 studied H. pylori infection
prevalence in Taiwan among children and young
adults to determine differences between urban
and rural settlement areas. They divided 567 chil-
dren and young adults into six groups (0—3, 3—6, 6—
9, 9—12, 12—15, and 15—18 years) and directed a
questionnaire to at least 30 persons from each
group. They found that the total prevalence was
13.7%, that the minimum prevalence (2%) was
observed in the 0—3 year age group and that the
prevalence increased linearly with age, reaching a
maximum level of 23.8% in the 9—12 year age group
before declining. Furthermore, they found that the
settlement area, sex, education of the mother, jobs
of the parents and whether or not there was a peptic
ulcer case in the family did not influence H. pylori
infection. They found that stomach pain (p = 0.001)
and education of the father (p = 0.039) had an
important relationship with H. pylori infection.
Similarly, this present study showed that stomach
pain had a significant correlation with the H. pylori
infection (p = 0.0002).
In a fecoprevalence study carried out in Canada
among Indian and Eskimo children between six
months and 12 years of age, in which H. pylori
antigen was investigated in stool samples by using
EIA, prevalence was reported as 56% (163/92). Sex,
owning pets, serum hemoglobin and the existence
of occult blood in stool had no relation with the
H. pylori prevalence. However, researchers have
pointed out that the use of toilets outside the house
was influential in H. pylori infections occurring at an
early age such as six months.30 In the present study,
HpSA fecoprevalence in patients 25despite the suspicion of H. pylori infection, the
prevalence in the 2—15 year age group was 25%,
lower than prevalence found in the above study. This
may be due to the fact that the present study was
carried out on children living in areas benefiting
from a good infrastructure in Istanbul.
Malfertheiner et al.,31 in the Maastricht 2-2000
Consensus Report, underlined the necessity of H.
pylori diagnosis and treatment in adults under 45
years of age with persistent dyspepsia (the age level
may change locally). The results of the present
study show that the probability of H. pylori infection
is high in patients with complaints of stomach pain,
nausea, vomiting, indigestion and gas. It is neces-
sary to test these patients for H. pylori.
This study is the first prevalence search based on
the determination of the H. pylori antigen in stool
samples in Turkey. The results have shown that the
prevalence of H. pylori infection in Turkey is as high
as 36.6%.
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